Skip to contentSPIEGELMAN DANIEL K — BIOMARIN PHARMACEUTICAL INC insider: 322 transactions · InsiderLensSPIEGELMAN DANIEL K
- Director at XCYTE THERAPIES INC · on record since Jul 11, 2006
- Director at Kyverna Therapeutics, Inc. · on record since Feb 7, 2024
- Director at AFFYMAX INC · on record since Dec 14, 2006
- Director at vTv Therapeutics Inc. · on record since Jun 27, 2024
- Director at Oncothyreon Inc. · on record since Jun 11, 2008
- Director at SPRUCE BIOSCIENCES, INC. · on record since May 26, 2026
- Director at OMEROS CORP · on record since Dec 9, 2009
- Director at Anthera Pharmaceuticals Inc · on record since Feb 23, 2010
- EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC · on record since May 31, 2012
- Director at Relypsa Inc · on record since Jun 23, 2014
- Director at Maze Therapeutics, Inc. · on record since Jun 10, 2026
- Director at CASCADE CORP · on record since Jun 28, 2016
- Director at MYRIAD GENETICS INC · on record since May 28, 2020
- Director at Jiya Acquisition Corp. · on record since Nov 18, 2020
- SVP, CFO at CV THERAPEUTICS INC · on record since Aug 30, 2005
Insider trading activity of SPIEGELMAN DANIEL K
- Transactions on record
- 322
- since Dec 12, 2003
- Open-market buys
- 4
- $64.4K
- Open-market sells
- 57
- $30.8M
- Companies traded
- 14
- last filing Jun 29, 2026
Figures computed from official regulatory filings — methodology.
Companies where SPIEGELMAN DANIEL K has traded
- vTv Therapeutics Inc.3 tx · $169.7K · Jun 29, 2026
- Maze Therapeutics, Inc.2 tx · Jun 10, 2026
- SPRUCE BIOSCIENCES, INC.12 tx · May 26, 2026
- Kyverna Therapeutics, Inc.2 tx · Jun 2, 2025
- MYRIAD GENETICS INC12 tx · $792.3K · Jun 4, 2024
- BIOMARIN PHARMACEUTICAL INC132 tx · $45.4M · Jun 7, 2019
- CASCADE CORP16 tx · $17.7K · Mar 13, 2018
- Relypsa Inc11 tx · $131.1K · Sep 2, 2016
- Oncothyreon Inc.29 tx · $184.6K · Sep 28, 2015
Track record of SPIEGELMAN DANIEL K
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of SPIEGELMAN DANIEL K
Co-insiders of SPIEGELMAN DANIEL K
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · Jun 16, 2014
EASTLAND JULIA MARIECASCADE CORP +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 29, 2026 | AwardD | 6,000 | 35.08 USD | — | SEC |
| Jun 10, 2026 | AwardD | 18,000 | 0.00 USD | $0 | SEC |
| May 26, 2026 | AwardD | 1,700 | 0.00 USD | $0 | SEC |
| Dec 15, 2025 | OtherD | -400 | — | — | SEC |
| Dec 15, 2025 | OtherD | -458 | — | — | SEC |
| Dec 15, 2025 | OtherD | -88 | — | — | SEC |
| Dec 15, 2025 | AwardD | 400 | — | — | SEC |
| Dec 15, 2025 | AwardD | 88 | — | — | SEC |
| Dec 15, 2025 | AwardD | 458 | — | — | SEC |
| Sep 24, 2025 | AwardD | 18,000 | 0.00 USD | $0 | SEC |
| Jul 24, 2025 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 12, 2025 | AwardD | 4,000 | 16.59 USD | $66.4K | SEC |
| Jun 2, 2025 | Award | 16,634 | 0.00 USD | $0 | SEC |
| Jun 2, 2025 | AwardD | 65,351 | 0.00 USD | $0 | SEC |
| Jun 27, 2024 | AwardD | 6,000 | 17.22 USD | $103.3K | SEC |
| Jun 4, 2024 | Sell | -3,788 | 22.04 USD | $83.5K | SEC |
| Jun 4, 2024 | Sell | -3,788 | 22.05 USD | $83.5K | SEC |
| May 24, 2024 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 2, 2023 | Sell | -8,638 | 23.01 USD | $198.8K | SEC |
| Jun 2, 2023 | Award | 15,151 | 0.00 USD | $0 | SEC |
| May 26, 2023 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 6, 2022 | Sell | -6,424 | 19.25 USD | $123.7K | SEC |
| Jun 3, 2022 | Award | 17,275 | 0.00 USD | $0 | SEC |
| May 27, 2022 | AwardD | 22,500 | 0.00 USD | $0 | SEC |
| Jun 17, 2021 | Sell | -3,139 | 30.52 USD | $95.8K | SEC |